FIELD OF THE INVENTION
The present invention relates to improved ophthalmic formulations, particularly to ophthalmic formulations which use an improved preservative system comprising a quaternary ammonium preservative and a stabilizing amount of a nonionic polyoxyethylated octylphenol surfactant for
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a method for the treatment of ophthalmic diseases originating from or associated with inflammation.
2. Related Disclosure
Many ophthalmic diseases are ocular disorders which are either caused or associated with painful
FIELD OF THE INVENTION
The invention relates to the use of biologically active glutarimide derivatives or pharmaceutically acceptable salts thereof as agents for the treatment of eosinophilic diseases.
BACKGROUND
Eosinophils are cells of the innate immunity. They are produced in the bone marrow and
BACKGROUND OF THE INVENTION
The present invention relates to a novel and useful azaazulene derivatives and salts thereof having antiallergic activity and antiinflammatory activity which are based on inhibitory activity against chemical mediator release, 5-lipoxygenase inhibiting activity or relaxing
BACKGROUND OF THE INVENTION
The present invention relates to improved ophthalmic formulations, particularly to ophthalmic formulations for anti-inflammatory drugs, and specifically to an improved preservative system for ophthalmic formulations of carboxyl ("--COOH") group-containing drugs,
FIELD OF THE INVENTION
The present invention relates to methods for treating eye disorders and to compositions comprising a Clostridium toxin for treating said disorders. In particular, the methods are related to treating eye disorders associated with inflammation.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to methods for treating eye disorders and to compositions comprising a Clostridium toxin for treating said disorders. In particular, the methods are related to treating eye disorders associated with inflammation.
BACKGROUND OF THE
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Stage application under 35 U.S.C. .sctn. 371 of International Application PCT/RU2014/000855 (published as WO 2015/072893 A1), filed Nov. 12, 2014, which claims priority to Application RU 2013150861, filed Nov. 14, 2013.
اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها. * تستند جميع المعلومات إلى البحوث العلمية المنشورة